A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

of whom 18.2% had HPV-negative results and negative intraepithelial lesion or malignancy (NILM) cytologic findings and 25.5% had abnormal results, reported Jasmin Tiro, PhD, of the University of ...

"Nearly all premalignant cervical lesions and cervical cancers ... HPV16-positive high-grade cervical intraepithelial neoplasia: a Phase II trial, Clinical Cancer Research (2025).

Sufficient scientific evidence exists to recommend HPV DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor lesions. However, due to a low ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

The cause of cervical cancer and its precursor lesions is almost always the human papillomavirus HPV with its higher-risk subtypes. However, immunodeficiency, multiparity (different sexual partners), ...

vaginal cancer, cervical high grade squamous intraepithelial lesion (HSIL), uterine cancer and high grade HPV-related vulvar intraepithelial neoplasia, cervical intraepithelial neoplasia, high grade ...